Core Insights - Premarket trading is showing notable activity with early price movements indicating potential opportunities before the market opens [1] Premarket Gainers - Mawson Infrastructure Group Inc. (MIGI) is up 10% at $5.65 [3] - Mingteng International Corporation Inc. (MTEN) is up 9% at $1.88 [3] - Barnwell Industries, Inc. (BRN) is up 9% at $1.20 [3] - Amentum Holdings, Inc. (AMTM) is up 8% at $27.57 [3] - Antelope Enterprise Holdings Limited (AEHL) is up 8% at $2.75 [3] - Protagenic Therapeutics, Inc. (PTIX) is up 8% at $2.43 [3] - Envirotech Vehicles, Inc. (EVTV) is up 8% at $1.18 [3] - Vir Biotechnology, Inc. (VIR) is up 6% at $6.49 [3] - Zoom Communications Inc. (ZM) is up 5% at $82.73 [3] - Core AI Holdings (CHAI) is up 5% at $2.68 [3] Premarket Losers - Foxx Development Holdings Inc. (FOXX) is down 13% at $4.00 [4] - Jaguar Health, Inc. (JAGX) is down 11% at $1.13 [4] - AlphaTON Capital Corp. (ATON) is down 7% at $2.54 [4] - Semtech Corporation (SMTC) is down 6% at $65.81 [4] - Cypherpunk Technologies Inc. (CYPH) is down 5% at $1.73 [4] - SunPower Inc. (SPWR) is down 5% at $1.59 [4] - Visionary Holdings Inc. (GV) is down 4% at $1.23 [4] - Gelteq Limited (GELS) is down 4% at $1.01 [4] - Capricor Therapeutics, Inc. (CAPR) is down 3% at $4.47 [4] - Mobile-Network Solutions (MNDR) is down 3% at $2.82 [4]

Core Insights - eXp Realty's CEO Leo Pareja has been recognized in The 2025 MarketWatch 25 list for his innovative leadership in the real estate industry [2][3][4] - Pareja's vision focuses on transparency, accessibility, and empowerment, aiming to build trust and enhance agent success while creating a connected experience for consumers globally [3][4] Company Overview - eXp World Holdings, Inc. is the parent company of eXp Realty and SUCCESS Enterprises, with eXp Realty being the largest independent real estate brokerage globally, boasting over 83,000 agents across 28 countries [6] - The company operates as a cloud-based, agent-centric brokerage, offering industry-leading commission splits, revenue share, equity ownership opportunities, and a global network for agents [6] Leadership and Recognition - Leo Pareja's leadership is characterized by innovation and collaboration, which are core values of eXp Realty, emphasizing agent empowerment and market transparency [4][5] - Pareja's inclusion in the MarketWatch 25 highlights eXp Realty's role in challenging traditional real estate norms and shaping the future of the industry [4][5]

Core Insights - Visionary Holdings Inc. has officially launched its medical-grade stem cell anti-aging product line, targeting the Chinese mainland and broader Asian markets [1][2] - This launch follows the company's entry into the stem cell and medical aesthetics sector and a strategic partnership with Jiangsu Yike Regenerative Medicine Co., Ltd. [2][3] Product Lines and Value Model - The anti-aging product portfolio includes three major categories: Life Rejuvenation Program, Precision Repair Package, and Premium Personalized Program [6] - The Life Rejuvenation Program combines mesenchymal stem cells, NK cell therapy, and AI-based diagnostics, aimed at high-net-worth individuals [6] - The Precision Repair Package integrates targeted stem cell therapy and blood purification for clients with specific conditions [6] - The Premium Personalized Program offers full-genome sequencing and customized health management for ultra-high-net-worth clients [6] Commercialization Strategy - The new products will be operated through the Asia-Pacific headquarters in Hong Kong, initially launching in Hong Kong, Singapore, and the Chinese mainland [4] - The company plans to establish a joint venture for localized manufacturing and validation of stem cell products [7] - A cross-border sales and distribution network will be built, covering mainland China, Hong Kong, Southeast Asia, and expanding into Canada, the United States, and Mexico [7] Management Perspective - The CEO of Visionary Holdings emphasized that the launch marks a significant milestone in converting technological assets into commercial value [4] - The company anticipates that this product line will drive profitability in upcoming fiscal years and enhance its visibility in global capital markets [5]

Core Insights - Visionary Holdings Inc. successfully convened the First Meeting of the Fourth Board of Directors, adopting all core proposals unanimously, which establishes a solid institutional foundation for the Company's future operations [1][2]. Governance Structure - The meeting resulted in the election of key positions: Mr. William T. Chai as Chairman, Mr. Kealey Donald M as Vice Chairman, Mr. Rusheng Wu as Managing Director, and Mr. Jun Huang as Executive Director, with Ms. Yongqiu Wang appointed as Company Secretary [2][3]. - Four specialized committees were established: Audit Committee, Nomination Committee, Compensation Committee, and Investment Committee, each with a focus on enhancing decision-making and risk control capabilities [3][4]. Management Team - A new senior management team was appointed, including Mr. Xiyong Hou as CEO, Mr. Jun Huang as Co-CEO, Mr. Robert Jay LEES as COO, and Ms. Xiaolan Liu as CFO, aimed at improving operational quality and global expansion [4][5]. Governance Improvement - The meeting adopted various procedural documents to clarify powers and responsibilities, standardize processes, and support efficient operations, with a focus on compliance and operational optimization [5][6]. Strategic Focus - The newly elected Chairman emphasized the commitment to compliance, investor interests, and value creation in high-end stem cell aesthetics and big health technology, aiming for sustainable development and industry ecosystem upgrades [6][7].

Core Points - Visionary Holdings Inc. successfully held its 2025 Annual General Meeting (AGM) with 97.79% of voting rights represented, exceeding quorum requirements [1] - All core agenda items, including board renewal and auditor reappointment, were approved with an overwhelming majority, establishing a solid governance foundation for the upcoming fiscal year [2] I. Board Renewal - The company renewed its Board of Directors, adhering to U.S. SEC and Nasdaq standards for director independence, with 16 candidates selected from 18 profiles [3] - Nine candidates were officially elected to the 4th Session of the Board, receiving over two-thirds of affirmative votes, with their term lasting until the end of the 2026 AGM [4] - The new board members bring diverse professional backgrounds, enhancing strategic decision-making and governance structure [5] II. Reappointment of Auditors - The AGM approved the reappointment of Assentsure PAC as the auditor for the 2025-2026 fiscal year, ensuring compliance with U.S. SEC and Nasdaq audit supervision requirements [6] - Assentsure PAC has a strong track record, having completed the previous fiscal year's audit efficiently, and will continue to ensure accurate financial disclosures [7] III. Review of Annual Reports - The financial report for the 2024-2025 fiscal year was approved, highlighting that 78% of revenue came from core businesses, with a 100% year-on-year growth in net profit from new health projects [9] - The company maintained total assets of USD 68,792 thousand and an asset-liability ratio of 80%, indicating a stable financial structure [9] - Strategic progress included establishing branches in China, acquiring new clients, and enhancing international brand influence [10] IV. Confirmation of Statutory Matters - The AGM confirmed the legality of the board election results, the appointment of Assentsure PAC, and the compliance of the 2024-2025 Form 20-F with regulatory requirements [12] V. Follow-up Arrangements - The first meeting of the new Board of Directors is scheduled for November 3, 2025, to elect key positions and appoint senior management, with resolutions to be disclosed promptly [13] Conclusion - The Board of Directors emphasized a commitment to shareholder responsibility and business development, aiming to enhance core competitiveness and deliver long-term value [14]

Core Insights - Conviva is positioned as the only platform that identifies consumer experience and engagement patterns, which enhances outcomes across applications, websites, and AI agents [1] Company Overview - Conviva specializes in analyzing consumer experience and engagement, providing insights that can lead to improved performance in various digital platforms [1] Industry Context - The focus on consumer experience and engagement is increasingly critical in the digital landscape, where companies seek to optimize interactions across multiple channels, including apps and AI [1]

Group 1 - The FX Super One Middle East launch event took place at the Armani Hotel in Burj Khalifa, Dubai, marking a significant milestone for the company [1] - Distinguished guests included representatives from the Qatari Government, Ajman Royal Family, and various investment groups, indicating strong regional interest and support [1] - Key executives from FF, including Global co-CEO Matthias Aydt and FX brand CEO Max Ma, were present, highlighting the leadership's commitment to the Middle East market [2] Group 2 - The event featured a forward-looking statement, suggesting that the company is focused on transparency regarding factors that may impact business and financial results [3]

Core Points - Visionary Holdings Inc. received a notification from Nasdaq regarding non-compliance with Listing Rule 5250(c)(1) due to a delay in filing its Annual Report on Form 20-F for the fiscal year ended March 31, 2025 [1] - The notification does not have an immediate effect on the listing or trading of the Company's shares, and the Company has 60 days to submit a compliance plan [2] - Visionary is actively working with its independent auditor to complete the audit process and file the Form 20-F as soon as possible [3] Company Overview - Visionary Holdings Inc. is a private education service provider based in Markham, Ontario, Canada, operating in both private and public education sectors [4]

Core Viewpoint - Visionary Holdings Inc. has signed a strategic cooperation agreement with Jiangsu Yike Regenerative Medical Technology Co., Ltd. to establish a joint venture, Visionary Yike Stemcell Technologies Inc., aimed at advancing stem cell research and commercialization globally [1][5]. Group 1: Joint Venture Details - The joint venture will focus on stem cell therapy, immune cell engineering, and AI-supported anti-aging diagnostics, leveraging Yike's proprietary platform and GV's global market infrastructure [3]. - GV will hold an 85% equity stake in the joint venture, while Yike will hold 15% [3]. - The joint venture aims to create a vertically integrated regenerative medicine enterprise encompassing R&D, trials, manufacturing, and global sales [3]. Group 2: Location and Infrastructure - The headquarters for the joint venture is proposed to be located at GV's property in Toronto, which spans over 40,000 square meters [2]. - The parties are evaluating the feasibility of developing cleanrooms, low-temperature biostorage, and related infrastructures to support future operations [2]. Group 3: Strategic Importance - The establishment of the joint venture is seen as a transformative milestone for GV's global health strategy, with potential for long-term value creation [4]. - This collaboration is expected to enhance GV's positioning in the North American stem cell sector and reflects a commitment to global innovation and shareholder value [5]. Group 4: Company Background - Visionary Holdings Inc. is a technology-driven multinational enterprise focused on innovative education, AI applications, and high-tech healthcare solutions, operating across North America and Asia [6]. - Jiangsu Yike Regenerative Medicine specializes in regenerative medicine and precision anti-aging technologies, holding numerous international patents and certifications [7].

Core Viewpoint - Visionary Copper and Gold Mines Inc. is initiating a non-brokered private placement to raise up to $3.0 million to fund a drilling campaign at its 100% owned Pt. Leamington Project in Newfoundland [1] Offering Details - The Offering will consist of three components: 1. Up to 1,560,000 hard dollar units (HD Units) priced at C$0.75 each, aiming for gross proceeds of up to C$1,170,000 [2] 2. Up to 1,333,333 flow-through units (FT Units) priced at C$1.11 each, targeting gross proceeds of up to $1,480,000 [2] 3. Up to 267,175 Manitoba flow-through units (MB FT Units) priced at C$1.31 each, with gross proceeds of up to $350,000 [2] Unit Composition - Each HD Unit will consist of one common share and one-half of one transferable common share purchase warrant [3] - Each FT Unit and MB FT Unit will consist of one flow-through common share and one-half of one transferable Warrant [3] Use of Proceeds - Gross proceeds from the sale of FT Units will be allocated to eligible "Canadian exploration expenses" related to the Pt. Leamington Project, with all qualifying expenditures renounced in favor of the subscribers effective December 31, 2025 [4] - Net proceeds from the sale of HD Units will be utilized for working capital and general corporate purposes [4] Company Overview - Visionary Copper and Gold Mines Inc. is focused on advancing its portfolio of base and precious metals deposits in established Canadian mining jurisdictions, particularly the Pt. Leamington Deposit in Newfoundland [7] - The company has reported an indicated mineral resource of 5.0 million tonnes grading 2.5 g/t AuEq, equating to 402,000 ounces of AuEq [7] - The company is also permitting the Rainbow deposit at its Pine Bay Project, with significant mineral resources reported [7]